About this Event
Thank you for enrolling in our randomized controlled trial for patients with Rheumatoid Arthritis (RA). After enrollment, the researchers randomly assigned all participants into a control group or an intervention group. Randomization helps to ensure that no bias affects the selection of people for either group. This letter is to inform you that you have been selected to be part of the control group for this study.
The purpose of a control group in this randomized controlled trial is to identify any comparative benefit from the new lifestyle intervention to that of standard treatment for RA. As part of the control group, you play a key role in the outcome of this study. It is important to continue your standard treatment and complete the required tasks throughout the study period.
What are the requirements of participating in the control group?
We will be asking you to complete the following tests and questionnaires five times over the next two years. Because we understand these asks may take time out of your day to complete, we will be compensating you between $40 - $100 at the completion of each task (for a total of $300).
Dried Blood Spot (DBS)/Waist circumference/blood pressure reading: Please sign up now to attend one of the live informational “how-to” session to learn how to complete this at-home test.
Health Assessment questionnaire (HAQ): You will be asked to complete this pain assessment questionnaire.
Medic*tion record: You will be asked to provide information on medications you are currently taking and any changes to those medications over the 2-year study period.
Health Confidence questionnaire: You will be asked to complete a 1-question survey on health confidence.
Each of the listed requirements will be done at the start of the study, at month 3, month 6, month 12 and month 24 for a total of five times.
What’s next?
Please choose a date and time below that works best for you to attend an informational session on how-to perform the above tasks. You must attend this meeting to continue participating in this study. If you are unable to attend either of the “How-to” sessions, please let the principal investigator, Keri LeCompte know by contacting her at [email protected] or at 802-371-3660.
Register Now:
Monday, December 19th from 12:30 – 1:00pm EST
Wednesday, January 4th from 5:30 – 6:00pm EST
Event Venue
Online
USD 0.00
